Skip to content
Clinical Trials – home
Recruiting

Study of Autologous Microfat and Platelet-Rich Plasma Injection Compared to Wrist Denervation in Patients with Radiocarpal Osteoarthritis

Verified siteInvestigational
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

What is this trial about?

A plain-language summary of the goals, design and what participants do

This study focuses on treating radiocarpal osteoarthritis, a condition that causes pain and stiffness in the wrist joint where the forearm bones meet the small bones of the wrist. The study compares two different treatments: a new approach using an injection that combines a person's own fat tissue (called autologous microfat) and platelet-rich plasma (called PRP) versus a standard surgical procedure called total wrist denervation, which involves cutting specific nerves to reduce pain.

The purpose is to determine if the injection treatment works as well as the standard surgical treatment for managing wrist pain. The injection mixture contains 2 milliliters of processed fat tissue and 2 milliliters of concentrated platelets, both taken from the patient's own body. This mixture is injected directly into the affected wrist joint.

During the study, patients will receive either the injection treatment or undergo the surgical denervation procedure. The effects of both treatments will be monitored for six months, with special attention paid to how well they reduce pain. The injection treatment, if proven effective, could offer patients a less invasive alternative to surgery for treating painful wrist arthritis.

The research process

The trial runs in 5 steps – from screening to follow-up. Each step says what happens and what the team monitors.

  1. Step 1

    Initial evaluation and preparation

    Your wrist pain and mobility will be evaluated using a visual analog scale (a tool to measure pain intensity from 0 to 100)

    A medical professional will review your wrist X-rays and arthroscanner results to confirm radiocarpal osteoarthritis (joint damage in the wrist)

  2. Step 2

    Group assignment

    You will be randomly assigned to one of two treatment groups:

    Group 1: Receiving an injection of autologous microfat (fat tissue from your own body) combined with platelet-rich plasma (concentrated platelets from your blood)

    Group 2: Receiving total wrist denervation (standard surgical procedure to reduce wrist pain)

  3. Step 3

    Treatment administration

    If assigned to Group 1: You will receive a single injection into your wrist joint containing 2 mL of microfat mixed with 2 mL of platelet-rich plasma

    If assigned to Group 2: You will undergo the standard wrist denervation procedure

  4. Step 4

    Follow-up period

    Your pain levels will be monitored and measured using the same scale as before treatment

    The main evaluation of treatment effectiveness will occur 6 months after the procedure

    Additional assessments may include wrist strength testing using a special device called a Jamar dynamometer

  5. Step 5

    Study completion

    The study will conclude with a final evaluation of your wrist pain and function

    Total participation time in the study will be 6 months from the treatment date

Who can join the trial?

13 criteria

  • Must be at least 18 years old (men and women can participate)
  • Must have wrist osteoarthritis with:
    • Pain score of at least 40 on a 0-100 scale
    • May have reduced hand strength or limited wrist movement affecting daily activities
    • Condition must be confirmed by X-rays showing joint changes
    • Must have tried standard medical treatments for at least one year, including:
      • Pain medications
      • Anti-inflammatory drugs
      • Wrist support brace
      • Physical therapy
      • Previous joint injections (if received)
      • Must sign an informed consent form agreeing to participate in the study
      • For women who can become pregnant:
        • Must have a negative pregnancy test
        • Must use reliable birth control during the study
        • Must be covered by a social security system

Who cannot join the trial?

15 criteria

  • Age below 18 or above 75 years
  • Previous surgery on the affected wrist
  • Presence of inflammatory arthritis (a condition where the immune system attacks the joints)
  • Active infection in the wrist area
  • Coagulation disorders (problems with blood clotting)
  • Current treatment with blood thinners
  • Pregnancy or breastfeeding
  • Known allergy to local anesthetics
  • Presence of autoimmune diseases (conditions where the immune system attacks healthy body tissues)
  • Active cancer or ongoing cancer treatment
  • Inability to follow study procedures or attend follow-up visits
  • Participation in another clinical trial within the past 30 days
  • Severe psychiatric conditions that may interfere with the study
  • Platelet count below normal range (platelets are blood cells that help with clotting)
  • Uncontrolled diabetes
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

We usually reply within a few days

Verified sites

All sites with verified contact details – recruitment status may not be available; ask directly

Trial locations

Where you can join this trial

Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.

Recruiting
Not finding your country?

Not sure what to do next?

Joining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.

See the full process and FAQ

Investigated drugs

  • Autologous Microfat with Platelet-Rich Plasma (PRP)

    This is a combination therapy where fat tissue and platelet-rich plasma are taken from the patient's own body. The fat is processed into tiny particles (microfat), and blood is processed to concentrate the platelets. These are then combined and injected into the wrist joint. This treatment aims to reduce pain and inflammation in patients with wrist arthritis.

  • Total Wrist Denervation

    This is a surgical procedure that involves cutting specific nerves around the wrist joint to reduce pain signals. It is considered the standard treatment for severe wrist arthritis when other treatments haven't worked. The procedure aims to provide pain relief while maintaining wrist movement.

What is already known about the treatment

  • Autologous Microfat with PRP

    A combination therapy consisting of the patient's own processed fat tissue (microfat) mixed with platelet-rich plasma (PRP) that is injected directly into the wrist joint. This innovative treatment is being studied for radiocarpal osteoarthritis as an alternative to surgical denervation, utilizing the natural healing and regenerative properties of both fat tissue and concentrated platelets. The mechanism of action involves the release of growth factors and stem cells that can potentially reduce inflammation, promote tissue repair, and alleviate joint pain. The treatment is administered as a single intra-articular injection and represents a minimally invasive approach in orthopedic medicine.

  • Platelet-Rich Plasma (PRP)

    A concentrated form of the patient's own blood platelets suspended in plasma, prepared through a specialized centrifugation process. This injectable treatment contains high levels of growth factors and bioactive proteins that stimulate tissue healing and reduce inflammation when administered directly into the affected joint. PRP is widely used in regenerative medicine and orthopedics, showing promising results in treating various musculoskeletal conditions, with its main advantage being the use of the body's own healing mechanisms without synthetic medications.

Investigated diseases

Radiocarpal Osteoarthritis - A degenerative joint disease affecting the wrist joint where the radius bone meets the first row of carpal bones. The condition involves gradual wearing down of the cartilage that cushions the joint surfaces between the radius and carpal bones. Over time, the smooth cartilage surface becomes rough and thin, leading to friction between bones during movement. The condition typically develops slowly and causes stiffness and reduced range of motion in the wrist. Common symptoms include pain during wrist movement, swelling around the joint, and a grinding sensation when moving the wrist.
Trial detailsLast updated 2 Oct 2026
Age18+ yearsPhasePhase IITrial ID2024-516239-28-00Estimated enrolment36 patientsSponsorAssistance Publique Hopitaux De Marseille

sourced from the EU Clinical Trials Register and site verification

Want to learn more about this trial or check if you can participate?

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).